Montelukast Prescribing at MODALITY PARTNERSHIP (HULL)
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
5,644
Total Quantity
153.7K
NHS Cost
£8.3K
vs National Avg
+724.3%
MODALITY PARTNERSHIP (HULL) prescribed 5,644 items of Montelukast over the last 12 months at a cost of £8,265 to the NHS. This is 724.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
453
Jun 2026
477
Jun 2026
493
Jun 2026
474
Jun 2026
471
Jun 2026
486
Jun 2026
470
Jun 2026
479
Jun 2026
485
Jun 2026
424
Jun 2026
463
Jun 2026
469
Prescribing Details
| Total Items | 5,644 |
|---|---|
| Total Quantity | 153,687 |
| Total NHS Cost | £8,265 |
| Presentations | 5 different forms |
| vs National Average | +724.3% |
Montelukast Prescribing Comparison
| This practice | 5,644 items |
|---|---|
| National average per practice | 685 items |
| Difference | +724.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.